i-Pharm Consulting’s Post

Sustainability is more than just a goal, it's becoming a defining factor in the biopharma industry. 🌍 A recent comprehensive survey of over 800 biopharma executives highlights the growing importance of sustainability, with 62% of companies identifying it as a top priority. The benefits are clear: improved brand reputation, increased profits, higher share prices, and enhanced talent attraction. Executives like David Butler of Hongene Biotech emphasise the strategic and financial sense of pursuing sustainable practices, citing long-term cost savings as a key driver. The potential rewards for companies, and for the planet are immense. ______________ Do you see any challenges that could come with these opportunities? Comment your thoughts below! #biopharma #iPharm #sustainability

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics